Loading…
Reported covered position: Chief of Staff, Representative Kurt Schrader
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Lower Costs, More Transparency Act
Client: KAISER FOUNDATION HEALTH PLANS · Firm: BLUESTONE STRATEGIES, LLC
Federally-Funded Healthcare Programs including Medicaid and Medicare Advantage (MA) and the CY 2025 Medicare Advantage Advance Rate Notice. The Lower Costs, More Transparency Act (HR 5378)
Lower Costs, More Transparency Act
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA) · Firm: BLUESTONE STRATEGIES, LLC
Pharmacy contracting issues related to drug pricing and pharmacy networks. HR 5378, The Lower Costs More Transparency Act S. 127, The PBM Transparency Act - Issues related to the FTC study of Pharmacy Benefit Managers. S. 1339, The Pharmacy Benefit Manager Reform Act - Issues related to the banning of spread pricing and rebate pass throughs S. 1967, The Patients Before Middlemen Act - Issues related to delinking and limiting PBMS ability to manage pharmacy benefits in Medicare.
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
NORTHWEST POWER AND CONSERVATION COUNCIL via BLUESTONE STRATEGIES, LLC
2026 · third_quarter · Q3
Advocacy and congressional engagement regarding the Councils draft Ninth Power Plan and 2026 Columbia River Basin Fish and Wildlife Program, including regional energy reliability, resource adequacy, and fish and wildlife conservation priorities.
Advocacy and congressional engagement regarding the Councils draft Ninth Power Plan and 2026 Columbia River Basin Fish and Wildlife Program, including regional energy reliability, resource adequacy, and fish and wildlife conservation priorities.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Source: Senate LDA
| EVOLVE FOUNDATION INTERNATIONAL |
| 4 |
| 2023 |
| VALOR COALITION | 4 | 2025 |
| MODERN ECONOMY PROJECT | 2 | 2023 |
Lower Costs, More Transparency Act
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA) · Firm: BLUESTONE STRATEGIES, LLC
Pharmacy contracting issues related to drug pricing and pharmacy networks. HR 5378, The Lower Costs More Transparency Act S. 127, The PBM Transparency Act - Issues related to the FTC study of Pharmacy Benefit Managers. S. 1339, The Pharmacy Benefit Manager Reform Act - Issues related to the banning of spread pricing and rebate pass throughs S. 1967, The Patients Before Middlemen Act - Issues related to delinking and limiting PBMS ability to manage pharmacy benefits in Medicare.
Lower Costs, More Transparency Act
Client: KAISER FOUNDATION HEALTH PLANS · Firm: BLUESTONE STRATEGIES, LLC
Federally-Funded Healthcare Programs including Medicaid and Medicare Advantage (MA) and the CY 2025 Medicare Advantage Advance Rate Notice. The Lower Costs, More Transparency Act (HR 5378)
Lower Costs, More Transparency Act
Client: AMERICA'S HEALTH INSURANCE PLANS (AHIP) · Firm: BLUESTONE STRATEGIES, LLC
Federally-Funded Healthcare Programs including Medicaid and Medicare Advantage (MA) and the CY 2025 Medicare Advantage Advance Rate Notice. The Lower Costs, More Transparency Act (HR 5378)
Lower Costs, More Transparency Act
Client: AMERICA'S HEALTH INSURANCE PLANS (AHIP) · Firm: BLUESTONE STRATEGIES, LLC
Federally-Funded Healthcare Programs including Medicaid and Medicare Advantage (MA) and the CY 2025 Medicare Advantage Advance Rate Notice. The Lower Costs, More Transparency Act (HR 5378)
Lower Costs, More Transparency Act
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA) · Firm: BLUESTONE STRATEGIES, LLC
Issues related to prescription drug coverage and pharmacy benefits. HR 5378, The Lower Costs More Transparency Act S. 127, The PBM Transparency Act - Issues related to the FTC study of Pharmacy Benefit Managers. S. 1339, The Pharmacy Benefit Manager Reform Act - Issues related to the banning of spread pricing and rebate pass throughs S. 1967, The Patients Before Middlemen Act - Issues related to delinking and limiting PBMS ability to manage pharmacy benefits in Medicare.
Lower Costs, More Transparency Act
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA) · Firm: BLUESTONE STRATEGIES, LLC
Issues related to prescription drug coverage and pharmacy benefits. HR 5378, The Lower Costs More Transparency Act S. 127, The PBM Transparency Act - Issues related to the FTC study of Pharmacy Benefit Managers. S. 1339, The Pharmacy Benefit Manager Reform Act - Issues related to the banning of spread pricing and rebate pass throughs S. 1967, The Patients Before Middlemen Act - Issues related to delinking and limiting PBMS ability to manage pharmacy benefits in Medicare.
Pharmacy Benefit Manager Transparency Act of 2023
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA) · Firm: BLUESTONE STRATEGIES, LLC
Issues related to prescription drug coverage and pharmacy benefits. HR 5378, The Lower Costs More Transparency Act S. 127, The PBM Transparency Act - Issues related to the FTC study of Pharmacy Benefit Managers. S. 1339, The Pharmacy Benefit Manager Reform Act - Issues related to the banning of spread pricing and rebate pass throughs S. 1967, The Patients Before Middlemen Act - Issues related to delinking and limiting PBMS ability to manage pharmacy benefits in Medicare.
Pharmacy Benefit Manager Transparency Act of 2023
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA) · Firm: BLUESTONE STRATEGIES, LLC
Pharmacy contracting issues related to drug pricing and pharmacy networks. HR 5378, The Lower Costs More Transparency Act S. 127, The PBM Transparency Act - Issues related to the FTC study of Pharmacy Benefit Managers. S. 1339, The Pharmacy Benefit Manager Reform Act - Issues related to the banning of spread pricing and rebate pass throughs S. 1967, The Patients Before Middlemen Act - Issues related to delinking and limiting PBMS ability to manage pharmacy benefits in Medicare.
Pharmacy Benefit Manager Transparency Act of 2023
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA) · Firm: BLUESTONE STRATEGIES, LLC
Issues related to prescription drug coverage and pharmacy benefits. HR 5378, The Lower Costs More Transparency Act S. 127, The PBM Transparency Act - Issues related to the FTC study of Pharmacy Benefit Managers. S. 1339, The Pharmacy Benefit Manager Reform Act - Issues related to the banning of spread pricing and rebate pass throughs S. 1967, The Patients Before Middlemen Act - Issues related to delinking and limiting PBMS ability to manage pharmacy benefits in Medicare.
Pharmacy Benefit Manager Transparency Act of 2023
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA) · Firm: BLUESTONE STRATEGIES, LLC
Pharmacy contracting issues related to drug pricing and pharmacy networks. HR 5378, The Lower Costs More Transparency Act S. 127, The PBM Transparency Act - Issues related to the FTC study of Pharmacy Benefit Managers. S. 1339, The Pharmacy Benefit Manager Reform Act - Issues related to the banning of spread pricing and rebate pass throughs S. 1967, The Patients Before Middlemen Act - Issues related to delinking and limiting PBMS ability to manage pharmacy benefits in Medicare.
Pharmacy Benefit Manager Reform Act
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA) · Firm: BLUESTONE STRATEGIES, LLC
Pharmacy contracting issues related to drug pricing and pharmacy networks. HR 5378, The Lower Costs More Transparency Act S. 127, The PBM Transparency Act - Issues related to the FTC study of Pharmacy Benefit Managers. S. 1339, The Pharmacy Benefit Manager Reform Act - Issues related to the banning of spread pricing and rebate pass throughs S. 1967, The Patients Before Middlemen Act - Issues related to delinking and limiting PBMS ability to manage pharmacy benefits in Medicare.
Pharmacy Benefit Manager Reform Act
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA) · Firm: BLUESTONE STRATEGIES, LLC
Issues related to prescription drug coverage and pharmacy benefits. HR 5378, The Lower Costs More Transparency Act S. 127, The PBM Transparency Act - Issues related to the FTC study of Pharmacy Benefit Managers. S. 1339, The Pharmacy Benefit Manager Reform Act - Issues related to the banning of spread pricing and rebate pass throughs S. 1967, The Patients Before Middlemen Act - Issues related to delinking and limiting PBMS ability to manage pharmacy benefits in Medicare.
Pharmacy Benefit Manager Reform Act
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA) · Firm: BLUESTONE STRATEGIES, LLC
Issues related to prescription drug coverage and pharmacy benefits. HR 5378, The Lower Costs More Transparency Act S. 127, The PBM Transparency Act - Issues related to the FTC study of Pharmacy Benefit Managers. S. 1339, The Pharmacy Benefit Manager Reform Act - Issues related to the banning of spread pricing and rebate pass throughs S. 1967, The Patients Before Middlemen Act - Issues related to delinking and limiting PBMS ability to manage pharmacy benefits in Medicare.
Pharmacy Benefit Manager Reform Act
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA) · Firm: BLUESTONE STRATEGIES, LLC
Pharmacy contracting issues related to drug pricing and pharmacy networks. HR 5378, The Lower Costs More Transparency Act S. 127, The PBM Transparency Act - Issues related to the FTC study of Pharmacy Benefit Managers. S. 1339, The Pharmacy Benefit Manager Reform Act - Issues related to the banning of spread pricing and rebate pass throughs S. 1967, The Patients Before Middlemen Act - Issues related to delinking and limiting PBMS ability to manage pharmacy benefits in Medicare.
PBM Act
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA) · Firm: BLUESTONE STRATEGIES, LLC
Issues related to prescription drug coverage, supply chain, and pharmacy benefits. S. 1967, The Patients Before Middlemen Act - Issues related to delinking and limiting PBMS ability to manage pharmacy benefits in Medicare.
PBM Act
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA) · Firm: BLUESTONE STRATEGIES, LLC
Issues related to prescription drug coverage, supply chain, and pharmacy benefits. S. 1967, The Patients Before Middlemen Act - Issues related to delinking and limiting PBMS ability to manage pharmacy benefits in Medicare.
PBM Act
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA) · Firm: BLUESTONE STRATEGIES, LLC
Pharmacy contracting issues related to drug pricing and pharmacy networks. HR 5378, The Lower Costs More Transparency Act S. 127, The PBM Transparency Act - Issues related to the FTC study of Pharmacy Benefit Managers. S. 1339, The Pharmacy Benefit Manager Reform Act - Issues related to the banning of spread pricing and rebate pass throughs S. 1967, The Patients Before Middlemen Act - Issues related to delinking and limiting PBMS ability to manage pharmacy benefits in Medicare.
PBM Act
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA) · Firm: BLUESTONE STRATEGIES, LLC
Pharmacy contracting issues related to drug pricing and pharmacy networks. HR 5378, The Lower Costs More Transparency Act S. 127, The PBM Transparency Act - Issues related to the FTC study of Pharmacy Benefit Managers. S. 1339, The Pharmacy Benefit Manager Reform Act - Issues related to the banning of spread pricing and rebate pass throughs S. 1967, The Patients Before Middlemen Act - Issues related to delinking and limiting PBMS ability to manage pharmacy benefits in Medicare.
PBM Act
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA) · Firm: BLUESTONE STRATEGIES, LLC
Issues related to prescription drug coverage and pharmacy benefits. HR 5378, The Lower Costs More Transparency Act S. 127, The PBM Transparency Act - Issues related to the FTC study of Pharmacy Benefit Managers. S. 1339, The Pharmacy Benefit Manager Reform Act - Issues related to the banning of spread pricing and rebate pass throughs S. 1967, The Patients Before Middlemen Act - Issues related to delinking and limiting PBMS ability to manage pharmacy benefits in Medicare.
PBM Act
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA) · Firm: BLUESTONE STRATEGIES, LLC
Issues related to prescription drug coverage and pharmacy benefits. HR 5378, The Lower Costs More Transparency Act S. 127, The PBM Transparency Act - Issues related to the FTC study of Pharmacy Benefit Managers. S. 1339, The Pharmacy Benefit Manager Reform Act - Issues related to the banning of spread pricing and rebate pass throughs S. 1967, The Patients Before Middlemen Act - Issues related to delinking and limiting PBMS ability to manage pharmacy benefits in Medicare.
Energy Permitting Reform Act of 2024
Client: NORTHWEST POWER AND CONSERVATION COUNCIL · Firm: BLUESTONE STRATEGIES, LLC
S.4753, the Energy Permitting Reform Act of 2024. Amendment to the permitting reform act lifting the prohibition on inflationary increase in the NWPCC budget
Lower Costs, More Transparency Act
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA) · Firm: BLUESTONE STRATEGIES, LLC
Issues related to prescription drug coverage and pharmacy benefits. HR 5378, The Lower Costs More Transparency Act S. 127, The PBM Transparency Act - Issues related to the FTC study of Pharmacy Benefit Managers. S. 1339, The Pharmacy Benefit Manager Reform Act - Issues related to the banning of spread pricing and rebate pass throughs S. 1967, The Patients Before Middlemen Act - Issues related to delinking and limiting PBMS ability to manage pharmacy benefits in Medicare.
Lower Costs, More Transparency Act
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA) · Firm: BLUESTONE STRATEGIES, LLC
Pharmacy contracting issues related to drug pricing and pharmacy networks. HR 5378, The Lower Costs More Transparency Act S. 127, The PBM Transparency Act - Issues related to the FTC study of Pharmacy Benefit Managers. S. 1339, The Pharmacy Benefit Manager Reform Act - Issues related to the banning of spread pricing and rebate pass throughs S. 1967, The Patients Before Middlemen Act - Issues related to delinking and limiting PBMS ability to manage pharmacy benefits in Medicare.
Pharmacy Benefit Manager Transparency Act of 2023
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA) · Firm: BLUESTONE STRATEGIES, LLC
Issues related to prescription drug coverage and pharmacy benefits. S. 127, The PBM Transparency Act - Issues related to the FTC study of Pharmacy Benefit Managers. S. 1339, The Pharmacy Benefit Manager Reform Act - Issues related to the banning of spread pricing and rebate pass throughs S. 1967, The Patients Before Middlemen Act - Issues related to delinking and limiting PBMS ability to manage pharmacy benefits in Medicare.
Pharmacy Benefit Manager Transparency Act of 2023
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA) · Firm: BLUESTONE STRATEGIES, LLC
Pharmacy contracting issues related to drug pricing and pharmacy networks. S. 127, The PBM Transparency Act - Issues related to the FTC study of Pharmacy Benefit Managers. S. 1339, The Pharmacy Benefit Manager Reform Act - Issues related to the banning of spread pricing and rebate pass throughs S. 1967, The Patients Before Middlemen Act - Issues related to delinking and limiting PBMS ability to manage pharmacy benefits in Medicare. .
Pharmacy Benefit Manager Transparency Act of 2023
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA) · Firm: BLUESTONE STRATEGIES, LLC
Pharmacy contracting issues related to drug pricing and pharmacy networks. S. 127, The PBM Transparency Act - Issues related to the FTC study of Pharmacy Benefit Managers.
Pharmacy Benefit Manager Transparency Act of 2023
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA) · Firm: BLUESTONE STRATEGIES, LLC
Issues related to prescription drug coverage and pharmacy benefits. S. 127, The PBM Transparency Act - Issues related to the FTC study of Pharmacy Benefit Managers. S. 1339, The Pharmacy Benefit Manager Reform Act - Issues related to the banning of spread pricing and rebate pass throughs S. 1967, The Patients Before Middlemen Act - Issues related to delinking and limiting PBMS ability to manage pharmacy benefits in Medicare.
Pharmacy Benefit Manager Transparency Act of 2023
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA) · Firm: BLUESTONE STRATEGIES, LLC
Issues related to prescription drug coverage and pharmacy benefits. S. 127, The PBM Transparency Act - Issues related to the FTC study of Pharmacy Benefit Managers.
Pharmacy Benefit Manager Transparency Act of 2023
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA) · Firm: BLUESTONE STRATEGIES, LLC
Pharmacy contracting issues related to drug pricing and pharmacy networks. S. 127, The PBM Transparency Act - Issues related to the FTC study of Pharmacy Benefit Managers. S. 1339, The Pharmacy Benefit Manager Reform Act - Issues related to the banning of spread pricing and rebate pass throughs S. 1967, The Patients Before Middlemen Act - Issues related to delinking and limiting PBMS ability to manage pharmacy benefits in Medicare. .
Pharmacy Benefit Manager Transparency Act of 2023
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA) · Firm: BLUESTONE STRATEGIES, LLC
Issues related to prescription drug coverage and pharmacy benefits. HR 5378, The Lower Costs More Transparency Act S. 127, The PBM Transparency Act - Issues related to the FTC study of Pharmacy Benefit Managers. S. 1339, The Pharmacy Benefit Manager Reform Act - Issues related to the banning of spread pricing and rebate pass throughs S. 1967, The Patients Before Middlemen Act - Issues related to delinking and limiting PBMS ability to manage pharmacy benefits in Medicare.
Pharmacy Benefit Manager Transparency Act of 2023
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA) · Firm: BLUESTONE STRATEGIES, LLC
Pharmacy contracting issues related to drug pricing and pharmacy networks. HR 5378, The Lower Costs More Transparency Act S. 127, The PBM Transparency Act - Issues related to the FTC study of Pharmacy Benefit Managers. S. 1339, The Pharmacy Benefit Manager Reform Act - Issues related to the banning of spread pricing and rebate pass throughs S. 1967, The Patients Before Middlemen Act - Issues related to delinking and limiting PBMS ability to manage pharmacy benefits in Medicare.
Pharmacy Benefit Manager Reform Act
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA) · Firm: BLUESTONE STRATEGIES, LLC
Pharmacy contracting issues related to drug pricing and pharmacy networks. S. 127, The PBM Transparency Act - Issues related to the FTC study of Pharmacy Benefit Managers. S. 1339, The Pharmacy Benefit Manager Reform Act - Issues related to the banning of spread pricing and rebate pass throughs S. 1967, The Patients Before Middlemen Act - Issues related to delinking and limiting PBMS ability to manage pharmacy benefits in Medicare. .
Pharmacy Benefit Manager Reform Act
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA) · Firm: BLUESTONE STRATEGIES, LLC
Pharmacy contracting issues related to drug pricing and pharmacy networks. HR 5378, The Lower Costs More Transparency Act S. 127, The PBM Transparency Act - Issues related to the FTC study of Pharmacy Benefit Managers. S. 1339, The Pharmacy Benefit Manager Reform Act - Issues related to the banning of spread pricing and rebate pass throughs S. 1967, The Patients Before Middlemen Act - Issues related to delinking and limiting PBMS ability to manage pharmacy benefits in Medicare.
Pharmacy Benefit Manager Reform Act
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA) · Firm: BLUESTONE STRATEGIES, LLC
Issues related to prescription drug coverage and pharmacy benefits. HR 5378, The Lower Costs More Transparency Act S. 127, The PBM Transparency Act - Issues related to the FTC study of Pharmacy Benefit Managers. S. 1339, The Pharmacy Benefit Manager Reform Act - Issues related to the banning of spread pricing and rebate pass throughs S. 1967, The Patients Before Middlemen Act - Issues related to delinking and limiting PBMS ability to manage pharmacy benefits in Medicare.
Pharmacy Benefit Manager Reform Act
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA) · Firm: BLUESTONE STRATEGIES, LLC
Issues related to prescription drug coverage and pharmacy benefits. S. 127, The PBM Transparency Act - Issues related to the FTC study of Pharmacy Benefit Managers. S. 1339, The Pharmacy Benefit Manager Reform Act - Issues related to the banning of spread pricing and rebate pass throughs S. 1967, The Patients Before Middlemen Act - Issues related to delinking and limiting PBMS ability to manage pharmacy benefits in Medicare.
Pharmacy Benefit Manager Reform Act
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA) · Firm: BLUESTONE STRATEGIES, LLC
Issues related to prescription drug coverage and pharmacy benefits. S. 127, The PBM Transparency Act - Issues related to the FTC study of Pharmacy Benefit Managers. S. 1339, The Pharmacy Benefit Manager Reform Act - Issues related to the banning of spread pricing and rebate pass throughs S. 1967, The Patients Before Middlemen Act - Issues related to delinking and limiting PBMS ability to manage pharmacy benefits in Medicare.
Pharmacy Benefit Manager Reform Act
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA) · Firm: BLUESTONE STRATEGIES, LLC
Pharmacy contracting issues related to drug pricing and pharmacy networks. S. 127, The PBM Transparency Act - Issues related to the FTC study of Pharmacy Benefit Managers. S. 1339, The Pharmacy Benefit Manager Reform Act - Issues related to the banning of spread pricing and rebate pass throughs S. 1967, The Patients Before Middlemen Act - Issues related to delinking and limiting PBMS ability to manage pharmacy benefits in Medicare. .
PBM Act
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA) · Firm: BLUESTONE STRATEGIES, LLC
Issues related to prescription drug coverage, supply chain, and pharmacy benefits. S. 1967, The Patients Before Middlemen Act - Issues related to delinking and limiting PBMS ability to manage pharmacy benefits in Medicare.
PBM Act
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA) · Firm: BLUESTONE STRATEGIES, LLC
Issues related to prescription drug coverage, supply chain, and pharmacy benefits. S. 1967, The Patients Before Middlemen Act - Issues related to delinking and limiting PBMS ability to manage pharmacy benefits in Medicare.
PBM Act
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA) · Firm: BLUESTONE STRATEGIES, LLC
Pharmacy contracting issues related to drug pricing and pharmacy networks. S. 127, The PBM Transparency Act - Issues related to the FTC study of Pharmacy Benefit Managers. S. 1339, The Pharmacy Benefit Manager Reform Act - Issues related to the banning of spread pricing and rebate pass throughs S. 1967, The Patients Before Middlemen Act - Issues related to delinking and limiting PBMS ability to manage pharmacy benefits in Medicare. .
PBM Act
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA) · Firm: BLUESTONE STRATEGIES, LLC
Issues related to prescription drug coverage, supply chain, and pharmacy benefits. S. 1967, The Patients Before Middlemen Act - Issues related to delinking and limiting PBMS ability to manage pharmacy benefits in Medicare.
PBM Act
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA) · Firm: BLUESTONE STRATEGIES, LLC
Pharmacy contracting issues related to drug pricing and pharmacy networks. S. 127, The PBM Transparency Act - Issues related to the FTC study of Pharmacy Benefit Managers. S. 1339, The Pharmacy Benefit Manager Reform Act - Issues related to the banning of spread pricing and rebate pass throughs S. 1967, The Patients Before Middlemen Act - Issues related to delinking and limiting PBMS ability to manage pharmacy benefits in Medicare. .
PBM Act
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA) · Firm: BLUESTONE STRATEGIES, LLC
Issues related to prescription drug coverage and pharmacy benefits. HR 5378, The Lower Costs More Transparency Act S. 127, The PBM Transparency Act - Issues related to the FTC study of Pharmacy Benefit Managers. S. 1339, The Pharmacy Benefit Manager Reform Act - Issues related to the banning of spread pricing and rebate pass throughs S. 1967, The Patients Before Middlemen Act - Issues related to delinking and limiting PBMS ability to manage pharmacy benefits in Medicare.
PBM Act
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA) · Firm: BLUESTONE STRATEGIES, LLC
Pharmacy contracting issues related to drug pricing and pharmacy networks. HR 5378, The Lower Costs More Transparency Act S. 127, The PBM Transparency Act - Issues related to the FTC study of Pharmacy Benefit Managers. S. 1339, The Pharmacy Benefit Manager Reform Act - Issues related to the banning of spread pricing and rebate pass throughs S. 1967, The Patients Before Middlemen Act - Issues related to delinking and limiting PBMS ability to manage pharmacy benefits in Medicare.
PBM Act
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA) · Firm: BLUESTONE STRATEGIES, LLC
Issues related to prescription drug coverage and pharmacy benefits. S. 127, The PBM Transparency Act - Issues related to the FTC study of Pharmacy Benefit Managers. S. 1339, The Pharmacy Benefit Manager Reform Act - Issues related to the banning of spread pricing and rebate pass throughs S. 1967, The Patients Before Middlemen Act - Issues related to delinking and limiting PBMS ability to manage pharmacy benefits in Medicare.
PBM Act
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA) · Firm: BLUESTONE STRATEGIES, LLC
Issues related to prescription drug coverage and pharmacy benefits. S. 127, The PBM Transparency Act - Issues related to the FTC study of Pharmacy Benefit Managers. S. 1339, The Pharmacy Benefit Manager Reform Act - Issues related to the banning of spread pricing and rebate pass throughs S. 1967, The Patients Before Middlemen Act - Issues related to delinking and limiting PBMS ability to manage pharmacy benefits in Medicare.
KAISER FOUNDATION HEALTH PLANS via BLUESTONE STRATEGIES, LLC
2026 · third_quarter · Q3
Issues related to federally-funded healthcare programs including Medicaid and Medicare Advantage (MA), telehealth, prior-authorization, and prescription drugs.
Issues related to Medicare Advantage (MA), Medicaid, commercial health insurance, and drug pricing.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICA'S HEALTH INSURANCE PLANS (AHIP) via BLUESTONE STRATEGIES, LLC
2026 · third_quarter · Q3
Issues related to Medicare Advantage (MA), Medicaid, commercial health insurance, and drug pricing.
Issues related to federally-funded healthcare programs including Medicaid and Medicare Advantage (MA), telehealth, prior-authorization, and prescription drugs.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
KAISER FOUNDATION HEALTH PLANS via BLUESTONE STRATEGIES, LLC
2026 · second_quarter · Q2
Issues related to Medicare Advantage (MA), Medicaid, commercial health insurance, and drug pricing. ACA subsidies and Advanced Premium Tax Credits.
Issues related to federally-funded healthcare programs including Medicaid and Medicare Advantage (MA), telehealth, prior-authorization, and prescription drugs.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NORTHWEST POWER AND CONSERVATION COUNCIL via BLUESTONE STRATEGIES, LLC
2026 · second_quarter · Q2
Legislation lifting the prohibition on inflationary increase in the NWPCC budget
Legislation lifting the prohibition on inflationary increase in the NWPCC budget
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICA'S HEALTH INSURANCE PLANS (AHIP) via BLUESTONE STRATEGIES, LLC
2026 · second_quarter · Q2
Issues related to Medicare Advantage (MA), Medicaid, commercial health insurance, and drug pricing. ACA subsidies and Advanced Premium Tax Credits.
Issues related to federally-funded healthcare programs including Medicaid and Medicare Advantage (MA), telehealth, prior-authorization, and prescription drugs.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NORTHWEST POWER AND CONSERVATION COUNCIL via BLUESTONE STRATEGIES, LLC
2026 · first_quarter · Q1
Legislation lifting the prohibition on inflationary increase in the NWPCC budget
Legislation lifting the prohibition on inflationary increase in the NWPCC budget
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
KAISER FOUNDATION HEALTH PLANS via BLUESTONE STRATEGIES, LLC
2026 · first_quarter · Q1
Issues related to Medicare Advantage (MA), Medicaid, commercial health insurance, and drug pricing. ACA subsidies and Advanced Premium Tax Credits.
Issues related to federally-funded healthcare programs including Medicaid and Medicare Advantage (MA), telehealth, prior-authorization, and prescription drugs.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICA'S HEALTH INSURANCE PLANS (AHIP) via BLUESTONE STRATEGIES, LLC
2026 · first_quarter · Q1
Issues related to Medicare Advantage (MA), Medicaid, commercial health insurance, and drug pricing. ACA subsidies and Advanced Premium Tax Credits.
Issues related to federally-funded healthcare programs including Medicaid and Medicare Advantage (MA), telehealth, prior-authorization, and prescription drugs.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
KAISER FOUNDATION HEALTH PLANS via BLUESTONE STRATEGIES, LLC
2025 · fourth_quarter · Q4
Issues related to Medicare Advantage (MA), Medicaid, commercial health insurance, and drug pricing. ACA subsidies and Advanced Premium Tax Credits.
Issues related to federally-funded healthcare programs including Medicaid and Medicare Advantage (MA), telehealth, prior-authorization, and prescription drugs.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICA'S HEALTH INSURANCE PLANS (AHIP) via BLUESTONE STRATEGIES, LLC
2025 · fourth_quarter · Q4
Issues related to Medicare Advantage (MA), Medicaid, commercial health insurance, and drug pricing. ACA subsidies and Advanced Premium Tax Credits.
Issues related to federally-funded healthcare programs including Medicaid and Medicare Advantage (MA), telehealth, prior-authorization, and prescription drugs.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NORTHWEST POWER AND CONSERVATION COUNCIL via BLUESTONE STRATEGIES, LLC
2025 · fourth_quarter · Q4
Legislation lifting the prohibition on inflationary increase in the NWPCC budget
Legislation lifting the prohibition on inflationary increase in the NWPCC budget
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
KAISER FOUNDATION HEALTH PLANS via BLUESTONE STRATEGIES, LLC
2025 · third_quarter · Q3
Issues related to Medicare Advantage (MA), Medicaid, commercial health insurance, and drug pricing. ACA subsidies and Advanced Premium Tax Credits.
Issues related to federally-funded healthcare programs including Medicaid and Medicare Advantage (MA), telehealth, prior-authorization, and prescription drugs.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NORTHWEST POWER AND CONSERVATION COUNCIL via BLUESTONE STRATEGIES, LLC
2025 · third_quarter · Q3
Legislation lifting the prohibition on inflationary increase in the NWPCC budget
Legislation lifting the prohibition on inflationary increase in the NWPCC budget
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VALOR COALITION via BLUESTONE STRATEGIES, LLC
2025 · third_quarter · Q3
Expanding research funding for National Institute of Health and the Veterans Administration for PTSD treatments.
Expanding research funding for National Institute of Health and the Veterans Administration for PTSD treatments.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICA'S HEALTH INSURANCE PLANS (AHIP) via BLUESTONE STRATEGIES, LLC
2025 · third_quarter · Q3
Issues related to Medicare Advantage (MA), Medicaid, commercial health insurance, and drug pricing. ACA subsidies and Advanced Premium Tax Credits.
Issues related to federally-funded healthcare programs including Medicaid and Medicare Advantage (MA), telehealth, prior-authorization, and prescription drugs.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SERCO INC. via BLUESTONE STRATEGIES, LLC
2025 · third_quarter · 3T
Serco contract and contracting opportunities with the Department of Health and Human Services.
FAA Contract Tower Program and federal funding and staffing issues related to it
Serco contract and contracting opportunities with the Department of Defense including the NOMARS program and FY26 NDAA authorization and FY26 appropriations.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VALOR COALITION via BLUESTONE STRATEGIES, LLC
2025 · second_quarter · Q2
Expanding research funding for National Institute of Health and the Veterans Administration for PTSD treatments.
Expanding research funding for National Institute of Health and the Veterans Administration for PTSD treatments.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NORTHWEST POWER AND CONSERVATION COUNCIL via BLUESTONE STRATEGIES, LLC
2025 · second_quarter · Q2
Legislation lifting the prohibition on inflationary increase in the NWPCC budget
Legislation lifting the prohibition on inflationary increase in the NWPCC budget
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SERCO INC. via BLUESTONE STRATEGIES, LLC
2025 · second_quarter · Q2
Serco contract and contracting opportunities with the Department of Health and Human Services.
FAA Contract Tower Program and federal funding and staffing issues related to it
Serco contract and contracting opportunities with the Department of Defense including the NOMARS program and FY26 NDAA authorization and FY26 appropriations.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
KAISER FOUNDATION HEALTH PLANS via BLUESTONE STRATEGIES, LLC
2025 · second_quarter · Q2
Issues related to Medicare Advantage healthcare coverage, Medicaid, Commercial Health Insurance, and drug pricing. ACA Subsidies and Enhanced Tax Credits
Federally-Funded Healthcare Programs including Medicaid and Medicare Advantage (MA) and the CY 2026 Medicare Advantage Advance Rate Notice.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICA'S HEALTH INSURANCE PLANS (AHIP) via BLUESTONE STRATEGIES, LLC
2025 · second_quarter · Q2
Issues related to Medicare Advantage healthcare coverage, Medicaid, Commercial Health Insurance, drug pricing, ACA Subsidies and Enhanced Tax Credits
Federally-Funded Healthcare Programs including Medicaid and Medicare Advantage (MA) and the CY 2026 Medicare Advantage Advance Rate Notice.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VALOR COALITION via BLUESTONE STRATEGIES, LLC
2025 · first_quarter · Q1
Expanding research funding for National Institute of Health and the Veterans Administration for PTSD treatments.
Expanding research funding for National Institute of Health and the Veterans Administration for PTSD treatments.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NORTHWEST POWER AND CONSERVATION COUNCIL via BLUESTONE STRATEGIES, LLC
2025 · first_quarter · Q1
Legislation lifting the prohibition on inflationary increase in the NWPCC budget
Legislation lifting the prohibition on inflationary increase in the NWPCC budget
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICA'S HEALTH INSURANCE PLANS (AHIP) via BLUESTONE STRATEGIES, LLC
2025 · first_quarter · Q1
Issues related to Medicare Advantage healthcare coverage, Medicaid, Commercial Health Insurance, drug pricing, ACA Subsidies and Enhanced Tax Credits
Federally-Funded Healthcare Programs including Medicaid and Medicare Advantage (MA) and the CY 2026 Medicare Advantage Advance Rate Notice.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
KAISER FOUNDATION HEALTH PLANS via BLUESTONE STRATEGIES, LLC
2025 · first_quarter · Q1
Issues related to Medicare Advantage healthcare coverage, Medicaid, Commercial Health Insurance, and drug pricing. ACA Subsidies and Enhanced Tax Credits
Federally-Funded Healthcare Programs including Medicaid and Medicare Advantage (MA) and the CY 2026 Medicare Advantage Advance Rate Notice.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SERCO INC. via BLUESTONE STRATEGIES, LLC
2025 · first_quarter · Q1
Serco contract and contracting opportunities with the Department of Health and Human Services.
FAA Contract Tower Program and federal funding and staffing issues related to it
Serco contract and contracting opportunities with the Department of Defense including the NOMARS program and FY26 NDAA authorization and FY26 appropriations.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VALOR COALITION via BLUESTONE STRATEGIES, LLC
2025 · first_quarter · RR
Expanding research funding for National Institute of Health and the Veterans Administration for PTSD treatments.
Expanding research funding for National Institute of Health and the Veterans Administration for PTSD treatments.
HEALING BREAKTHROUGH via BLUESTONE STRATEGIES, LLC
2024 · fourth_quarter · Q4
Expanding research funding for National Institute of Health and the Veterans Administration for PTSD treatments.
Expanding research funding for National Institute of Health and the Veterans Administration for PTSD treatments.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SERCO INC. via BLUESTONE STRATEGIES, LLC
2024 · fourth_quarter · Q4
Serco contract and contracting opportunities with the Department of Health and Human Services.
FAA Contract Tower Program and federal funding related to it
Serco contract and contracting opportunities with the Department of Defense including the NOMARS program and FY25 appropriations
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
KAISER FOUNDATION HEALTH PLANS via BLUESTONE STRATEGIES, LLC
2024 · fourth_quarter · Q4
Federally-Funded Healthcare Programs including Medicaid and Medicare Advantage (MA) and the CY 2025 Medicare Advantage Advance Rate Notice. The Lower Costs, More Transparency Act (HR 5378)
Issues related to Medicare Advantage healthcare coverage, Medicaid, Commercial Health Insurance, and drug pricing. ACA Subsidies and Enhanced Tax Credits
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICA'S HEALTH INSURANCE PLANS (AHIP) via BLUESTONE STRATEGIES, LLC
2024 · fourth_quarter · Q4
Federally-Funded Healthcare Programs including Medicaid and Medicare Advantage (MA) and the CY 2025 Medicare Advantage Advance Rate Notice. The Lower Costs, More Transparency Act (HR 5378)
Issues related to Medicare Advantage healthcare coverage, Medicaid, Commercial Health Insurance, and drug pricing ACA Subsidies and Enhanced Tax Credits
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NORTHWEST POWER AND CONSERVATION COUNCIL via BLUESTONE STRATEGIES, LLC
2024 · fourth_quarter · Q4
S.4753, the Energy Permitting Reform Act of 2024. Amendment to the permitting reform act lifting the prohibition on inflationary increase in the NWPCC budget
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
KAISER FOUNDATION HEALTH PLANS via BLUESTONE STRATEGIES, LLC
2024 · third_quarter · Q3
Issues related to Medicare Advantage healthcare coverage, Medicaid, Commercial Health Insurance, and drug pricing. ACA Subsidies and Enhanced Tax Credits
Federally-Funded Healthcare Programs including Medicaid and Medicare Advantage (MA) and the CY 2025 Medicare Advantage Advance Rate Notice. The Lower Costs, More Transparency Act (HR 5378)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HEALING BREAKTHROUGH via BLUESTONE STRATEGIES, LLC
2024 · third_quarter · Q3
Expanding research funding for National Institute of Health and the Veterans Administration for PTSD treatments.
Expanding research funding for National Institute of Health and the Veterans Administration for PTSD treatments.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SERCO INC. via BLUESTONE STRATEGIES, LLC
2024 · third_quarter · Q3
Serco contract and contracting opportunities with the Department of Defense including the NOMARS program and FY25 appropriations
Serco contract and contracting opportunities with the Department of Health and Human Services.
FAA Contract Tower Program and federal funding related to it
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICA'S HEALTH INSURANCE PLANS (AHIP) via BLUESTONE STRATEGIES, LLC
2024 · third_quarter · Q3
Federally-Funded Healthcare Programs including Medicaid and Medicare Advantage (MA) and the CY 2025 Medicare Advantage Advance Rate Notice. The Lower Costs, More Transparency Act (HR 5378)
Issues related to Medicare Advantage healthcare coverage, Medicaid, Commercial Health Insurance, and drug pricing ACA Subsidies and Enhanced Tax Credits
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HEALING BREAKTHROUGH via BLUESTONE STRATEGIES, LLC
2024 · second_quarter · Q2
Expanding research funding for National Institute of Health and the Veterans Administration for PTSD treatments.
Expanding research funding for National Institute of Health and the Veterans Administration for PTSD treatments.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SERCO INC. via BLUESTONE STRATEGIES, LLC
2024 · second_quarter · Q2
Serco contract and contracting opportunities with the Department of Defense including the NOMARS program and FY25 appropriations
FAA Contract Tower Program and federal funding related to it
Serco contract and contracting opportunities with the Department of Health and Human Services.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICA'S HEALTH INSURANCE PLANS (AHIP) via BLUESTONE STRATEGIES, LLC
2024 · second_quarter · 2A
Federally-Funded Healthcare Programs including Medicaid and Medicare Advantage (MA) and the CY 2025 Medicare Advantage Advance Rate Notice.
Issues related to Medicare Advantage healthcare coverage, Medicaid, Commercial Health Insurance, and drug pricing
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
KAISER FOUNDATION HEALTH PLANS via BLUESTONE STRATEGIES, LLC
2024 · second_quarter · Q2
Issues related to Medicare Advantage healthcare coverage, Medicaid, Commercial Health Insurance, and drug pricing.
Federally-Funded Healthcare Programs including Medicaid and Medicare Advantage (MA) and the CY 2025 Medicare Advantage Advance Rate Notice.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICA'S HEALTH INSURANCE PLANS (AHIP) via BLUESTONE STRATEGIES, LLC
2024 · second_quarter · Q2
Federally-Funded Healthcare Programs including Medicaid and Medicare Advantage (MA) and the CY 2025 Medicare Advantage Advance Rate Notice.
Issues related to Medicare Advantage healthcare coverage, Medicaid, Commercial Health Insurance, and drug pricing
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA) via BLUESTONE STRATEGIES, LLC
2024 · second_quarter · 2T
Issues related to prescription drug coverage, supply chain, and pharmacy benefits. S. 1967, The Patients Before Middlemen Act - Issues related to delinking and limiting PBMS ability to manage pharmacy benefits in Medicare.
Issues related to prescription drug coverage and pharmacy benefits. HR 5378, The Lower Costs More Transparency Act S. 127, The PBM Transparency Act - Issues related to the FTC study of Pharmacy Benefit Managers. S. 1339, The Pharmacy Benefit Manager Reform Act - Issues related to the banning of spread pricing and rebate pass throughs S. 1967, The Patients Before Middlemen Act - Issues related to delinking and limiting PBMS ability to manage pharmacy benefits in Medicare.
HEALING BREAKTHROUGH via BLUESTONE STRATEGIES, LLC
2024 · first_quarter · Q1
Expanding research funding for National Institute of Health and the Veterans Administration for PTSD treatments.
Expanding research funding for National Institute of Health and the Veterans Administration for PTSD treatments.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SERCO INC. via BLUESTONE STRATEGIES, LLC
2024 · first_quarter · Q1
Serco contract and contracting opportunities with the Department of Health and Human Services.
FAA Contract Tower Program and federal funding related to it
Serco contract and contracting opportunities with the Department of Defense including the NOMARS program and FY25 appropriations
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
KAISER FOUNDATION HEALTH PLANS via BLUESTONE STRATEGIES, LLC
2024 · first_quarter · Q1
Issues related to Medicare Advantage healthcare coverage, Medicaid, Commercial Health Insurance, and drug pricing.
Federally-Funded Healthcare Programs including Medicaid and Medicare Advantage (MA) and the CY 2025 Medicare Advantage Advance Rate Notice.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICA'S HEALTH INSURANCE PLANS (AHIP) via BLUESTONE STRATEGIES, LLC
2024 · first_quarter · Q1
Issues related to Medicare Advantage healthcare coverage, Medicaid, Commercial Health Insurance, and drug pricing
Federally-Funded Healthcare Programs including Medicaid and Medicare Advantage (MA) and the CY 2025 Medicare Advantage Advance Rate Notice.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA) via BLUESTONE STRATEGIES, LLC
2024 · first_quarter · Q1
Pharmacy contracting issues related to drug pricing and pharmacy networks. HR 5378, The Lower Costs More Transparency Act S. 127, The PBM Transparency Act - Issues related to the FTC study of Pharmacy Benefit Managers. S. 1339, The Pharmacy Benefit Manager Reform Act - Issues related to the banning of spread pricing and rebate pass throughs S. 1967, The Patients Before Middlemen Act - Issues related to delinking and limiting PBMS ability to manage pharmacy benefits in Medicare.
Issues related to prescription drug coverage, supply chain, and pharmacy benefits. S. 1967, The Patients Before Middlemen Act - Issues related to delinking and limiting PBMS ability to manage pharmacy benefits in Medicare.
HEALING BREAKTHROUGH via BLUESTONE STRATEGIES, LLC
2023 · fourth_quarter · 4A
Expanding research funding for National Institute of Health and the Veterans Administration for PTSD treatments.
Expanding research funding for National Institute of Health and the Veterans Administration for PTSD treatments.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
KAISER FOUNDATION HEALTH PLANS via BLUESTONE STRATEGIES, LLC
2023 · fourth_quarter · Q4
Issues related to Medicare Advantage healthcare coverage, Medicaid, Commercial Health Insurance, and drug pricing.
Federally-Funded Healthcare Programs including Medicaid and Medicare Advantage (MA) and the CY 2024 Medicare Advantage Advance Rate Notice.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SERCO INC. via BLUESTONE STRATEGIES, LLC
2023 · fourth_quarter · Q4
Serco contract and contracting opportunities with the Department of Health and Human Services.
Serco contract and contracting opportunities with the Department of Defense
FAA Contract Tower Program
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA) via BLUESTONE STRATEGIES, LLC
2023 · fourth_quarter · Q4
Issues related to prescription drug coverage and pharmacy benefits. HR 5378, The Lower Costs More Transparency Act S. 127, The PBM Transparency Act - Issues related to the FTC study of Pharmacy Benefit Managers. S. 1339, The Pharmacy Benefit Manager Reform Act - Issues related to the banning of spread pricing and rebate pass throughs S. 1967, The Patients Before Middlemen Act - Issues related to delinking and limiting PBMS ability to manage pharmacy benefits in Medicare.
Pharmacy contracting issues related to drug pricing and pharmacy networks. HR 5378, The Lower Costs More Transparency Act S. 127, The PBM Transparency Act - Issues related to the FTC study of Pharmacy Benefit Managers. S. 1339, The Pharmacy Benefit Manager Reform Act - Issues related to the banning of spread pricing and rebate pass throughs S. 1967, The Patients Before Middlemen Act - Issues related to delinking and limiting PBMS ability to manage pharmacy benefits in Medicare.
KAISER FOUNDATION HEALTH PLANS via BLUESTONE STRATEGIES, LLC
2023 · first_quarter · 1A
Issues related to Medicare Advantage healthcare coverage, Medicaid, Commercial Health Insurance, and drug pricing.
Federally-Funded Healthcare Programs including Medicaid and Medicare Advantage (MA) and the CY 2024 Medicare Advantage Advance Rate Notice.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICA'S HEALTH INSURANCE PLANS (AHIP) via BLUESTONE STRATEGIES, LLC
2023 · fourth_quarter · Q4
Federally-Funded Healthcare Programs including Medicaid and Medicare Advantage (MA) and the CY 2024 Medicare Advantage Advance Rate Notice.
Issues related to Medicare Advantage healthcare coverage, Medicaid, Commercial Health Insurance, and drug pricing
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HEALING BREAKTHROUGH via BLUESTONE STRATEGIES, LLC
2023 · fourth_quarter · RR
Expanding research funding for National Institute of Health and the Veterans Administration for PTSD treatments.
Expanding research funding for National Institute of Health and the Veterans Administration for PTSD treatments.
EVOLVE FOUNDATION INTERNATIONAL via BLUESTONE STRATEGIES, LLC
2023 · third_quarter · 3T
Medical Research and Funding for Traumatic Brain Injury and Post-Traumatic Stress Disorder; National Defense Authorization Act research funding, VA and Department of Defense Appropriations
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA) via BLUESTONE STRATEGIES, LLC
2023 · third_quarter · Q3
Pharmacy contracting issues related to drug pricing and pharmacy networks. S. 127, The PBM Transparency Act - Issues related to the FTC study of Pharmacy Benefit Managers. S. 1339, The Pharmacy Benefit Manager Reform Act - Issues related to the banning of spread pricing and rebate pass throughs S. 1967, The Patients Before Middlemen Act - Issues related to delinking and limiting PBMS ability to manage pharmacy benefits in Medicare. .
Issues related to prescription drug coverage and pharmacy benefits. S. 127, The PBM Transparency Act - Issues related to the FTC study of Pharmacy Benefit Managers. S. 1339, The Pharmacy Benefit Manager Reform Act - Issues related to the banning of spread pricing and rebate pass throughs S. 1967, The Patients Before Middlemen Act - Issues related to delinking and limiting PBMS ability to manage pharmacy benefits in Medicare.
SERCO INC. via BLUESTONE STRATEGIES, LLC
2023 · third_quarter · Q3
Serco contract and contracting opportunities with the Department of Defense
FAA Contract Tower Program
Serco contract and contracting opportunities with the Department of Health and Human Services.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
KAISER FOUNDATION HEALTH PLANS via BLUESTONE STRATEGIES, LLC
2023 · third_quarter · Q3
Federally-Funded Healthcare Programs including Medicaid and Medicare Advantage (MA) and the CY 2024 Medicare Advantage Advance Rate Notice.
Issues related to Medicare Advantage healthcare coverage, Medicaid, Commercial Health Insurance, and drug pricing.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICA'S HEALTH INSURANCE PLANS (AHIP) via BLUESTONE STRATEGIES, LLC
2023 · third_quarter · Q3
Federally-Funded Healthcare Programs including Medicaid and Medicare Advantage (MA) and the CY 2024 Medicare Advantage Advance Rate Notice.
Issues related to Medicare Advantage healthcare coverage, Medicaid, Commercial Health Insurance, and drug pricing
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NORTHWEST POWER AND CONSERVATION COUNCIL via BLUESTONE STRATEGIES, LLC
2023 · third_quarter · RR
Columbia River Basin Fish and Wildlife Program and Northwest Power Plan
Columbia River Basin Fish and Wildlife Program and Northwest Power Plan
Columbia River Basin Fish and Wildlife Program and Northwest Power Plan
PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA) via BLUESTONE STRATEGIES, LLC
2023 · second_quarter · Q2
Issues related to prescription drug coverage, supply chain, and pharmacy benefits. S. 1967, The Patients Before Middlemen Act - Issues related to delinking and limiting PBMS ability to manage pharmacy benefits in Medicare.
Pharmacy contracting issues related to drug pricing and pharmacy networks. S. 127, The PBM Transparency Act - Issues related to the FTC study of Pharmacy Benefit Managers. S. 1339, The Pharmacy Benefit Manager Reform Act - Issues related to the banning of spread pricing and rebate pass throughs S. 1967, The Patients Before Middlemen Act - Issues related to delinking and limiting PBMS ability to manage pharmacy benefits in Medicare. .
EVOLVE FOUNDATION INTERNATIONAL via BLUESTONE STRATEGIES, LLC
2023 · second_quarter · Q2
Medical Research and Funding for Traumatic Brain Injury and Post-Traumatic Stress Disorder; National Defense Authorization Act research funding, VA and Department of Defense Appropriations
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SERCO INC. via BLUESTONE STRATEGIES, LLC
2023 · second_quarter · Q2
FAA Contract Tower Program
Serco contract and contracting opportunities with the Department of Defense
Serco contract and contracting opportunities with the Department of Health and Human Services.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
KAISER FOUNDATION HEALTH PLANS via BLUESTONE STRATEGIES, LLC
2023 · second_quarter · Q2
Federally-Funded Healthcare Programs including Medicaid and Medicare Advantage (MA) and the CY 2024 Medicare Advantage Advance Rate Notice.
Issues related to Medicare Advantage healthcare coverage, Medicaid, Commercial Health Insurance, and drug pricing.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICA'S HEALTH INSURANCE PLANS (AHIP) via BLUESTONE STRATEGIES, LLC
2023 · second_quarter · Q2
Issues related to Medicare Advantage healthcare coverage, Medicaid, Commercial Health Insurance, and drug pricing
Federally-Funded Healthcare Programs including Medicaid and Medicare Advantage (MA) and the CY 2024 Medicare Advantage Advance Rate Notice.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICA'S HEALTH INSURANCE PLANS (AHIP) via BLUESTONE STRATEGIES, LLC
2023 · first_quarter · Q1
Federally-Funded Healthcare Programs including Medicaid and Medicare Advantage (MA) and the CY 2024 Medicare Advantage Advance Rate Notice.
Issues related to Medicare Advantage healthcare coverage, Medicaid, Commercial Health Insurance, and drug pricing
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA) via BLUESTONE STRATEGIES, LLC
2023 · first_quarter · Q1
Pharmacy contracting issues related to drug pricing and pharmacy networks. S. 127, The PBM Transparency Act - Issues related to the FTC study of Pharmacy Benefit Managers.
Issues related to prescription drug coverage, supply chain, and pharmacy benefits.
Issues related to prescription drug coverage and pharmacy benefits. S. 127, The PBM Transparency Act - Issues related to the FTC study of Pharmacy Benefit Managers.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
KAISER FOUNDATION HEALTH PLANS via BLUESTONE STRATEGIES, LLC
2023 · first_quarter · Q1
Issues related to Medicare Advantage healthcare coverage, Medicaid, Commercial Health Insurance, and drug pricing.
Federally-Funded Healthcare Programs including Medicaid and Medicare Advantage (MA) and the CY 2024 Medicare Advantage Advance Rate Notice.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EVOLVE FOUNDATION INTERNATIONAL via BLUESTONE STRATEGIES, LLC
2023 · first_quarter · Q1
Medical Research and Funding for Traumatic Brain Injury and Post-Traumatic Stress Disorder; National Defense Authorization Act research funding, VA and Department of Defense Appropriations
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MODERN ECONOMY PROJECT via BLUESTONE STRATEGIES, LLC
2023 · first_quarter · Q1
NLRB funding and workforce issues related to the gig economy
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SERCO INC. via BLUESTONE STRATEGIES, LLC
2023 · first_quarter · Q1
Serco contract and contracting opportunities with the Department of Defense
FAA Contract Tower Program
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EVOLVE FOUNDATION INTERNATIONAL via BLUESTONE STRATEGIES, LLC
2023 · first_quarter · RR
expanding research funding for National Institute of Health and the Veterans Administration for PTSD treatments.
expanding research funding for National Institute of Health and the Veterans Administration for PTSD treatments.
MODERN ECONOMY PROJECT via BLUESTONE STRATEGIES, LLC
2023 · first_quarter · RR
Focus will be on educating government officials on economic policies related to labor, workforce, and employers.
Pharmacy contracting issues related to drug pricing and pharmacy networks. HR 5378, The Lower Costs More Transparency Act S. 127, The PBM Transparency Act - Issues related to the FTC study of Pharmacy Benefit Managers. S. 1339, The Pharmacy Benefit Manager Reform Act - Issues related to the banning of spread pricing and rebate pass throughs S. 1967, The Patients Before Middlemen Act - Issues related to delinking and limiting PBMS ability to manage pharmacy benefits in Medicare.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to prescription drug coverage and pharmacy benefits. HR 5378, The Lower Costs More Transparency Act S. 127, The PBM Transparency Act - Issues related to the FTC study of Pharmacy Benefit Managers. S. 1339, The Pharmacy Benefit Manager Reform Act - Issues related to the banning of spread pricing and rebate pass throughs S. 1967, The Patients Before Middlemen Act - Issues related to delinking and limiting PBMS ability to manage pharmacy benefits in Medicare.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to prescription drug coverage, supply chain, and pharmacy benefits. S. 1967, The Patients Before Middlemen Act - Issues related to delinking and limiting PBMS ability to manage pharmacy benefits in Medicare.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to prescription drug coverage, supply chain, and pharmacy benefits. S. 1967, The Patients Before Middlemen Act - Issues related to delinking and limiting PBMS ability to manage pharmacy benefits in Medicare.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Columbia River Basin Fish and Wildlife Program and Northwest Power Plan
Issues related to prescription drug coverage and pharmacy benefits. S. 127, The PBM Transparency Act - Issues related to the FTC study of Pharmacy Benefit Managers. S. 1339, The Pharmacy Benefit Manager Reform Act - Issues related to the banning of spread pricing and rebate pass throughs S. 1967, The Patients Before Middlemen Act - Issues related to delinking and limiting PBMS ability to manage pharmacy benefits in Medicare.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE